J Wright, V L Hillsamer, R E Gore-Langton, B D Cheson. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » AnimalsAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useBoronic Acids/adverse effectsBoronic Acids/therapeutic useBortezomibClinical Trials, Phase I as TopicClinical Trials, Phase II as TopicHematologic Neoplasms/drug therapyHumansNeoplasms/drug therapyProtease Inhibitors/adverse effectsProtease Inhibitors/therapeutic usePyrazines/adverse effectsPyrazines/therapeutic use
Substances： See more » Antineoplastic AgentsBoronic AcidsProtease InhibitorsPyrazinesBortezomib
Year: 2000 PMID： 11125942
Source DB: PubMed Journal: Oncology (Williston Park) ISSN： 0890-9091 Impact factor: 2.990